Table 2 Distribution by stage and histology
From: Pattern of use of radiotherapy for lung cancer: a descriptive study
NSCLC N = 494 (81%) | SCLC N = 116 (19%) | ||||||
|---|---|---|---|---|---|---|---|
Stage | N (%) radical | N (%) palliative | Total (%) | Stage | N (%) radical | N (%) palliative | Total (%) |
I | 17 (6.2) | 4 (2) | 21 (4.2) | ||||
II | 33 (12.1) | 8 (3.7) | 41 (8.3) | Limited | 82 (71) | - | 82 (71) |
III | 179(65.3) | 125 (57) | 304 (61.5) | ||||
IV | 45 (16.4) | 83 (37.3) | 128 (26) | Extended | - | 34 (29) | 34 (29) |
n = 610 | 274 (55.4) | 220 (44.6) | 494 (100) | 82 (71) | 34 (29) | 116 (100) | |